Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone for Chronic Pancreatitis and Insulin Resistance
NCT00782795Phase 2Completed
- Sponsor
- University of Michigan
- Start
- Nov 2008
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of pioglitazone in chronic pancreatitis (CP) and type 2 diabetes mellitus (T2DM), sponsored by University of Michigan. Primary endpoint: Glucose Tolerance at 48 weeks. Started Nov 2008; status: completed.
02
Drugs
pioglitazone
03
Conditions
chronic pancreatitis (CP)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00782795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00782795.